Fortis Healthcare Bidding War: Malaysia's IHH Healthcare Revises Offer
Fortis Healthcare Ltd received a revised bid from Malaysia's IHH Healthcare Bhd, it said on Tuesday, in a continuing takeover battle for the cash-strapped hospital chain operator. Fortis has been the target of five companies and investment groups, who are vying for control of its 30-odd hospitals in India, as the country's private healthcare market is set to grow sharply. IHH's latest proposal includes an immediate equity infusion at Rs 175 per share and a subsequent equity infusion at a per share price not exceeding Rs 175, the company said in a statement.
The revised bid comes on the last day for submitting binding bids, which Fortis's expert advisory committee will evaluate. The committee will share its recommendations to the board ahead of its meeting on May 10.
Last week, IHH tweaked an earlier bid and offered to immediately infuse Rs 650 crore under the binding portion of the proposal and subsequently invest up to Rs 3,350 crore under the non-binding part of the proposal.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
